Back

Drug Pricing Summary

VA FSS

$0.1733 - $16.9983

NADAC

$1.0551

VA Big4

$1.3568 - $16.9983

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
paricalcitol 1 ug (CAPSULE) $0.1733 VA FSS
  • Paricalcitol (30)
  • Zydus Pharmaceuticals (USA) Inc.
    paricalcitol 1 ug (CAPSULE) $1.0551 NADAC generic
  • Paricalcitol (1)
  • Aurobindo Pharma Limited
    paricalcitol 1 ug (CAPSULE) $8.4993 VA Big4
  • Zemplar (30)
  • Abbvie US LLC
    paricalcitol 1 ug (CAPSULE) $8.4993 VA FSS
  • Zemplar (30)
  • Abbvie US LLC
    paricalcitol 2 ug (CAPSULE) $1.4570 VA FSS
  • Paricalcitol (30)
  • Zydus Pharmaceuticals (USA) Inc.
    paricalcitol 2 ug (CAPSULE) $16.9983 VA Big4
  • Zemplar (30)
  • Abbvie US LLC
    paricalcitol 2 ug (CAPSULE) $16.9983 VA FSS
  • Zemplar (30)
  • Abbvie US LLC
    paricalcitol 2 ug / 1 mL (1 mL INJECTION) $0.8008 VA FSS
  • Paricalcitol (25)
  • Accord Healthcare Inc.
    paricalcitol 2 ug / 1 mL (1 mL INJECTION) $1.3568 VA Big4
  • Zemplar (100)
  • Abbvie US LLC
    paricalcitol 2 ug / 1 mL (1 mL INJECTION) $1.3568 VA FSS
  • Zemplar (100)
  • Abbvie US LLC
    paricalcitol 5 ug / 1 mL (1 mL INJECTION) $2.0276 VA FSS
  • Paricalcitol (25)
  • Accord Healthcare Inc.
    paricalcitol 5 ug / 1 mL (1 mL INJECTION) $2.5628 VA Big4
  • Zemplar (100)
  • Abbvie US LLC
    paricalcitol 5 ug / 1 mL (1 mL INJECTION) $2.5628 VA FSS
  • Zemplar (100)
  • Abbvie US LLC
    paricalcitol 5 ug / 1 mL (1 mL INJECTION) $2.8831 VA Big4
  • Zemplar (100)
  • Abbvie US LLC
    paricalcitol 5 ug / 1 mL (1 mL INJECTION) $3.3417 VA FSS
  • Zemplar (100)
  • Abbvie US LLC
    paricalcitol 5 ug / 1 mL (1 mL INJECTION) $3.9100 VA FSS
  • Paricalcitol (2)
  • Accord Healthcare Inc.

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue